SCHEMBL6199244

SCHEMBL6199244

CC(C)CC(O)c1ccc(C=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.55
ALDH1A3 P47895 2/20 0.41
CYP2A6 P11509 3/20 0.40
ALDH5A1 P51649 1/20 0.40
ABAT P80404 1/20 0.40
GRIA4 P48058 1/20 0.40
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
ALDH1A1 P00352 6/20 0.38
ALDH3A1 P30838 1/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9616688 0.80 LMNA (0.54) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL29861042 0.77 CTSS (0.39) ALDH1A1KDM4ETSHRNFKB1HIF1A
SCHEMBL6200956 0.77 TYR (0.67) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL11467358 0.77 TYR (0.55) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL3911748 0.77 TYR (0.50) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL12197898 0.75 ACHE (0.46) ALDH1A1KDM4ETSHRNFKB1HIF1A
Cuminaldehyde SCHEMBL2485456 0.75 TYR (0.86) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL1681794 0.75 TYR (0.48) TYRALDH1A3CYP2A6ALDH5A1ABAT
SCHEMBL5725101 0.74 S1PR2 (0.48) TYRALDH1A3ALDH1A1ALDH3A1KDM4E
SCHEMBL12243879 0.74 AOC3 (0.53) MAPK1TSHRHIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
CN-1384835-A Tricycle inhibitors of poly(ADP-ribose) polymerases AGOURON PHARMA (US) 2002-12-11 CN disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed